HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.

Abstract
Altered peripheral carbonyl stress markers, high levels of serum pentosidine, which accumulates following carbonyl stress, and low levels of pyridoxal (vitamin B6), which detoxifies reactive carbonyl compounds, have been reported in a cross-sectional study of chronic schizophrenia. However, changes in the levels of these compounds in patients with schizophrenia have not been investigated in a longitudinal study. To clarify whether these markers may be biological markers that reflect the clinical course of the disease, the serum levels of these compounds were investigated in a cross-sectional and a longitudinal study. One hundred and thirty-seven acute-stage Japanese patients were enrolled. Among these, 53 patients were followed from the acute stage to remission. A portion of patients in the acute stage (14 cases, 10.2%) showed extremely high pentosidine levels. These levels were not associated with the severity of symptoms but were associated with antipsychotic dose amounts. Pyridoxal levels were lower in schizophrenia and increased according to the clinical course of the illness. Furthermore, 18 patients with decreased pyridoxal levels according to the clinical course showed that the greater the decrease in pyridoxal levels, the lesser the improvement in symptoms. Thus, extremely high pentosidine levels in a portion of patients may be caused by higher daily antipsychotic doses, whereas pyridoxal levels were lower in schizophrenia and increased according to the clinical course. Patients with decreasing pyridoxal levels during the clinical course showed less improvement in symptoms. Carbonyl stress markers may also be therapeutic biological markers in some patients with schizophrenia.
AuthorsNarimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima, Yuto Takebayashi, Motoyuki Higa, Mayu Takeda, Toru Nakamura, Shohei Nishimon, Takahiro Sannohe, Yuri Hotta, Ryo Hanzawa, Ryoko Higashiyama, Nobuto Shibata, Heii Arai
JournalSchizophrenia bulletin (Schizophr Bull) Vol. 40 Issue 6 Pg. 1366-73 (Nov 2014) ISSN: 1745-1701 [Electronic] United States
PMID24448481 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: [email protected].
Chemical References
  • Antipsychotic Agents
  • Biomarkers
  • Pyridoxal
  • Arginine
  • pentosidine
  • Lysine
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents (administration & dosage, pharmacology)
  • Arginine (analogs & derivatives, blood)
  • Biomarkers (blood)
  • Cross-Sectional Studies
  • Female
  • Humans
  • Longitudinal Studies
  • Lysine (analogs & derivatives, blood)
  • Male
  • Middle Aged
  • Pyridoxal (blood)
  • Schizophrenia (blood, drug therapy)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: